Product correctly added to cart.

discount label
BTK IN-1
View 3D

Biosynth logo

BTK IN-1

CAS: 1270014-40-8

Ref. 3D-VAC01440

25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 18 Feb 2025

Product Information

Name:
BTK IN-1
Description:

BTK IN-1 is a novel antibody drug conjugate (ADC) that targets the BTK protein and is being developed for the treatment of chronic lymphocytic leukemia. The BTK protein is expressed in cells of the microenvironment where cancerous cells are found, and when activated, it can lead to cancer cell proliferation. Clinical data has shown that BTK IN-1 reduces plasma concentrations of BTK, which might be an indication that this ADC is specific to the target. In addition, clinical development has been conducted on patients with lymphocytic leukemia or chronic lymphocytic leukemia. According to these clinical studies, BTK IN-1 appears to be an effective drug against cancerous cells in the blood and bone marrow.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
384.86 g/mol
Formula:
C19H21ClN6O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-VAC01440 BTK IN-1

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".